<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Helen of Troy Limited

    Helen of Troy Limited

    Helen of Troy Limited (NASDAQ: HELE) is a leading global consumer products company...

    Helen of Troy Limited (NASDAQ: HELE) is a leadi...

    Filing Type:    PU
    Anika Therapeutics Inc.

    Anika Therapeutics Inc.

    Headquartered in Bedford, Massachusetts, Anika Therapeutics, Inc. develops, manufa...

    Headquartered in Bedford, Massachusetts, Anika ...

    Filing Type:    PU
    Spok Holdings, Inc.

    Spok Holdings, Inc.

    Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK), headq...

    Spok, Inc., a wholly owned subsidiary of Spok H...

    Filing Type:    PU
    Retrophin, Inc.

    Retrophin, Inc.

    We are a biopharmaceutical company focused on developing our pipeline featuring sp...

    We are a biopharmaceutical company focused on d...

    Filing Type:    PU
    Syneos Health, Inc.

    Syneos Health, Inc.

    Syneos HealthÂŽ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solut...

    Syneos HealthÂŽ (Nasdaq:SYNH) is the only fully...

    Filing Type:    PU
    Arena Pharmaceuticals, Inc.

    Arena Pharmaceuticals, Inc.

    Arena Pharmaceuticals is driven to deliver novel, transformational medicines with ...

    Arena Pharmaceuticals is driven to deliver nove...

    Filing Type:    PU
    Vascular Biogenics Ltd.

    Vascular Biogenics Ltd.

    VBL Therapeutics is a publicly traded (NASDAQ: VBLT), late-stage clinical biopharm...

    VBL Therapeutics is a publicly traded (NASDAQ: ...

    Filing Type:    PU
    Gossamer Bio, Inc.

    Gossamer Bio, Inc.

    Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering,...

    Gossamer Bio is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    ASLAN Pharmaceuticals Limited

    ASLAN Pharmaceuticals Limited

    ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company d...

    ASLAN Pharmaceuticals is a clinical-stage oncol...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.